Lisa Jerome

3.9k total citations · 1 hit paper
25 papers, 2.1k citations indexed

About

Lisa Jerome is a scholar working on Clinical Psychology, Pharmacology and Toxicology. According to data from OpenAlex, Lisa Jerome has authored 25 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Clinical Psychology, 16 papers in Pharmacology and 7 papers in Toxicology. Recurrent topics in Lisa Jerome's work include Psychedelics and Drug Studies (20 papers), Cannabis and Cannabinoid Research (16 papers) and Forensic Toxicology and Drug Analysis (7 papers). Lisa Jerome is often cited by papers focused on Psychedelics and Drug Studies (20 papers), Cannabis and Cannabinoid Research (16 papers) and Forensic Toxicology and Drug Analysis (7 papers). Lisa Jerome collaborates with scholars based in United States, Canada and United Kingdom. Lisa Jerome's co-authors include Rick Doblin, Michael C. Mithoefer, Ann T. Mithoefer, Mark T. Wagner, Berra Yazar‐Klosinski, Allison A. Feduccia, Amy Emerson, Scott Hamilton, Harry Sumnall and Jon C. Cole and has published in prestigious journals such as Scientific Reports, Psychopharmacology and Drug and Alcohol Dependence.

In The Last Decade

Lisa Jerome

24 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial

2018 272 citations Michael C. Mithoefer, Ann T. Mithoefer et al. The Lancet Psychiatry profile →

Peers

Lisa Jerome

CMN

PHARM

TOXIC

Michael C. Mithoefer United States

Rick Doblin United States

Berra Yazar‐Klosinski United States

John H. Halpern United States

Torsten Passie Germany

Yasmin Schmid Switzerland

Valerie H. Curran United Kingdom

José Carlos Bouso Spain

U. McCann United States

Tomáš Páleníček Czechia

Michael C. Mithoefer United States

Lisa Jerome

1.9k ×1.0

812 ×1.0

CMN

682 ×1.0

PHARM

607 ×1.0

397 ×0.9

TOXIC

Citations per year, relative to Lisa Jerome Lisa Jerome (= 1×) peers Michael C. Mithoefer

Countries citing papers authored by Lisa Jerome

Since Specialization

Citations

This map shows the geographic impact of Lisa Jerome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Jerome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Jerome more than expected).

Fields of papers citing papers by Lisa Jerome

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Jerome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Jerome. The network helps show where Lisa Jerome may publish in the future.

Co-authorship network of co-authors of Lisa Jerome

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Jerome. A scholar is included among the top collaborators of Lisa Jerome based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Jerome. Lisa Jerome is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Makunts, Tigran, et al.. (2023). Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system. Frontiers in Psychiatry. 14. 1149766–1149766. 3 indexed citations

Feduccia, Allison A., Lisa Jerome, Berra Yazar‐Klosinski, et al.. (2023). Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline. FOCUS The Journal of Lifelong Learning in Psychiatry. 21(3). 306–314. 6 indexed citations

Makunts, Tigran, et al.. (2022). Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database. Frontiers in Psychiatry. 12. 824288–824288. 10 indexed citations

Jerome, Lisa, et al.. (2021). Sleep Quality Improvements After MDMA‐Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder. Journal of Traumatic Stress. 34(4). 851–863. 33 indexed citations

Greenway, Kyle T., Nicolas Garel, Lisa Jerome, & Allison A. Feduccia. (2020). Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments. Expert Review of Clinical Pharmacology. 13(6). 655–670. 59 indexed citations

Feduccia, Allison A., Lisa Jerome, Julie B. Wang, et al.. (2020). MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study. Scientific Reports. 10(1). 20442–20442. 88 indexed citations

Monson, Candice M., Anne Catherine Wagner, Ann T. Mithoefer, et al.. (2020). MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial. European journal of psychotraumatology. 11(1). 1840123–1840123. 47 indexed citations

Feduccia, Allison A., Lisa Jerome, Berra Yazar‐Klosinski, et al.. (2019). Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline. Frontiers in Psychiatry. 10. 650–650. 108 indexed citations

Christiansen, Merete Bruun, et al.. (2019). The Past and Future of Psychedelic Science: An Introduction to This Issue. Journal of Psychoactive Drugs. 51(2). 93–97. 47 indexed citations

10.

Danforth, Alicia, Charles S. Grob, Allison A. Feduccia, et al.. (2018). Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology. 235(11). 3137–3148. 161 indexed citations

11.

Mithoefer, Michael C., Ann T. Mithoefer, Allison A. Feduccia, et al.. (2018). 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry. 5(6). 486–497. 272 indexed citations breakdown →

12.

G., Marcela Ot’alora, Jim Grigsby, Lisa Jerome, et al.. (2018). 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial. Journal of Psychopharmacology. 32(12). 1295–1307. 155 indexed citations

13.

Wagner, Mark T., Michael C. Mithoefer, Ann T. Mithoefer, et al.. (2017). Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy. Journal of Psychopharmacology. 31(8). 967–974. 89 indexed citations

14.

Emerson, Amy, et al.. (2014). History and Future of the Multidisciplinary Association for Psychedelic Studies (MAPS). Journal of Psychoactive Drugs. 46(1). 27–36. 33 indexed citations

15.

Jerome, Lisa, et al.. (2013). Can MDMA Play a Role in the Treatment of Substance Abuse?. Current Drug Abuse Reviews. 6(1). 54–62. 27 indexed citations

16.

Mithoefer, Michael C., Mark T. Wagner, Ann T. Mithoefer, et al.. (2012). Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. Journal of Psychopharmacology. 27(1). 28–39. 276 indexed citations

17.

Mithoefer, Michael C., Mark T. Wagner, Ann T. Mithoefer, Lisa Jerome, & Rick Doblin. (2010). The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology. 25(4). 439–452. 446 indexed citations

18.

Jerome, Lisa. (2008). D-Lysergic Acid Diethylamide (LSD) Investigator's Brochure. 2 indexed citations

19.

Cole, Jon C., et al.. (2006). The effects of stereotype threat on cognitive function in ecstasy users. Journal of Psychopharmacology. 20(4). 518–525. 29 indexed citations

20.

Gamma, Alex, Lisa Jerome, Matthias E. Liechti, & Harry Sumnall. (2004). Is ecstasy perceived to be safe? A critical survey. Drug and Alcohol Dependence. 77(2). 185–193. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact